Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.

Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ovulation induction which, at present, is being studied increasingly because of its frequent occurrence as a result of the growing number of in-vitro fertilization (IVF) programmes. The anatomical changes involving enlargement of the ovaries and increased capillary permeability leading to acute fluid shift have been traditionally proposed to explain the different clinical features observed in OHSS. Recent work from our group, however, has shown that the pathogenesis of severe OHSS is more complex than currently understood and that marked peripheral arteriolar vasodilation is a major event in the development of the syndrome. Peripheral vasodilation may, in its turn, alter microvascular haemodynamics and permeability. This leads to a circulatory dysfunction with marked homeostatic activation of endogenous vasoactive systems having vasoconstrictor and sodium- and water-retaining activities. In this way, sodium and water retention would be a cause rather than a consequence of ascites formation in severe OHSS. This report analyses current concepts on body fluid regulation as well as neurohormonal and haemodynamic studies both in patients with severe OHSS and asymptomatic IVF women, integrating their findings into the present knowledge of the pathogenesis of the syndrome. Therapeutic implications are discussed.

[1]  N. Mcintyre,et al.  Oxford Textbook of Clinical Hepatology , 1999 .

[2]  W. Jiménez,et al.  Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. , 1998, Human reproduction.

[3]  R. Casamitjana,et al.  Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. , 1998, The Journal of clinical endocrinology and metabolism.

[4]  W. Jiménez,et al.  Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion , 1998, Hepatology.

[5]  W. Jelkmann,et al.  Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. , 1998, Human reproduction.

[6]  J. Jenkins,et al.  The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. , 1997, Human reproduction.

[7]  R. Huhn,et al.  Leukocytosis in response to exogenous gonadotrophin stimulation. , 1997, Human reproduction.

[8]  J. Schenker,et al.  The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. , 1997, Human reproduction.

[9]  L. Wildt,et al.  O-013. HCG does not directly regulate circulating concentrations of vascular endothelial growth factor in IVF and embryo transfer cycles , 1997 .

[10]  V. De Maertelaer,et al.  Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. , 1997, Fertility and sterility.

[11]  J. Smitz,et al.  The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. , 1997, Human reproduction update.

[12]  J. Balasch,et al.  Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome. , 1996, Fertility and sterility.

[13]  F. Dhabhar,et al.  Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. , 1996, Journal of immunology.

[14]  M. Friedlander,et al.  Endocrinology: Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-α cannot predict its occurrence , 1996 .

[15]  J. Schenker,et al.  Endocrinology: Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome , 1996 .

[16]  W. Jiménez,et al.  Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach , 1996, Acta obstetricia et gynecologica Scandinavica.

[17]  M. Friedlander,et al.  Elevated Interleukin‐6 Levels in the Ovarian Hyperstimulation Syndrome: Ovarian Immunohistochemical Localization of Interleukin‐6 Signal , 1996, Obstetrics and gynecology.

[18]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[19]  J. Schenker,et al.  Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. , 1996, Human reproduction.

[20]  M. Friedlander,et al.  Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. , 1996, Human reproduction.

[21]  H. Karube,et al.  Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. , 1995, Fertility and sterility.

[22]  T. Gura Estrogen: key player in heart disease among women , 1995, Science.

[23]  W. Jiménez,et al.  Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. , 1995, Fertility and sterility.

[24]  B. Østerud Cellular interactions in tissue factor expression by blood monocytes , 1995 .

[25]  J. Francis,et al.  The clinical value of tissue factor assays , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[26]  P. August,et al.  Role of renin-angiotensin system in blood pressure regulation in pregnancy , 1995, The Lancet.

[27]  B. Osterud Cellular interactions in tissue factor expression by blood monocytes. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[28]  M. Samama,et al.  Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. , 1995, Human reproduction.

[29]  K. Inokuchi,et al.  Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. , 1995, Acta haematologica.

[30]  B. Brenner,et al.  Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .

[31]  W. Jiménez,et al.  Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome , 1994, Annals of Internal Medicine.

[32]  J. Laragh,et al.  Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[33]  D. Herrington,et al.  Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. , 1994, The American journal of cardiology.

[34]  A. Kably Ambe,et al.  [The ovarian hyperstimulation syndrome. Institutional experience]. , 1994, Ginecología y Obstetricia de México.

[35]  G. Remuzzi,et al.  Endothelins in the control of cardiovascular and renal function , 1993, The Lancet.

[36]  P. Øian,et al.  Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. , 1993, Human reproduction.

[37]  T. Masaki,et al.  Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. , 1993, Endocrine reviews.

[38]  B. Battistini,et al.  Endothelins: circulating plasma levels and presence in other biologic fluids. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[39]  W. Jiménez,et al.  Circulating levels of endothelin in cirrhosis. , 1993, Gastroenterology.

[40]  D. Webb,et al.  The endothelin family of peptides: local hormones with diverse roles in health and disease? , 1993, Clinical science.

[41]  Steven D. Carson,et al.  The role of tissue factor in the production of thrombin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[42]  N. Laufer,et al.  Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment , 1993 .

[43]  H. Yarali,et al.  The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. , 1993, Fertility and sterility.

[44]  J. Schenker Prevention and treatment of ovarian hyperstimulation. , 1993, Human reproduction.

[45]  K. Badr,et al.  Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.

[46]  J. Rouleau,et al.  Elevated Endothelin‐1 in Heart Failure and Loss of Normal Response to Postural Change , 1992, Circulation.

[47]  J. Llach,et al.  Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation , 1991, Fertility and sterility.

[48]  J. Koziol,et al.  Elevated serum interleukin‐6 levels in patients with reactive thrombocytosis , 1991, British journal of haematology.

[49]  M. Aboulghar,et al.  Modern management of ovarian hyperstimulation syndrome. , 1991, Human reproduction.

[50]  M. Pirovino,et al.  [Ovarian hyperstimulation syndrome]. , 1991, Schweizerische medizinische Wochenschrift.

[51]  O. Tanizawa,et al.  Increase in the concentration of immunoreactive endothelin in human pregnancy. , 1991, The Journal of endocrinology.

[52]  V. Briner,et al.  Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. , 1991, Obstetrics and gynecology.

[53]  J. Slater,et al.  The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin , 1991, Clinical endocrinology.

[54]  E. Cogan Atrial natriuretic factor and the endocrine control of electrolyte homeostasis. , 1991, Acta cardiologica.

[55]  B. Yuen,et al.  The Ovarian Hyperstimulation Syndrome , 1990 .

[56]  R. Schrier Body fluid volume regulation in health and disease: a unifying hypothesis. , 1990, Annals of internal medicine.

[57]  B. Brenner,et al.  Diverse biological actions of atrial natriuretic peptide. , 1990, Physiological reviews.

[58]  J. Llach,et al.  Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. , 1990, Human reproduction.

[59]  P. Baylis 3 Regulation of vasopressin secretion , 1989 .

[60]  Muñoz Sj Pathogenesis of sodium and water retention. , 1989 .

[61]  A. Golan,et al.  Ovarian hyperstimulation syndrome: an update review. , 1989 .

[62]  B. Lunenfeld,et al.  Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. , 1989, Fertility and sterility.

[63]  C. Rosenfeld,et al.  Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. , 1989, The American journal of physiology.

[64]  L. Kovács,et al.  Regulation of Vasopressin Secretion and Thirst , 1989 .

[65]  R. Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) , 1988, The New England journal of medicine.

[66]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[67]  J. Laragh,et al.  Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogen. , 1988, The Journal of clinical endocrinology and metabolism.

[68]  R. Korthuis,et al.  Intestinal capillary filtration in acute and chronic portal hypertension. , 1988, The American journal of physiology.

[69]  R. Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) , 1988, The New England journal of medicine.

[70]  F. Lang Physiology of diuretic action. , 1988, Renal physiology.

[71]  J. Schenker,et al.  Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. , 1987, Fertility and sterility.

[72]  J. Laragh,et al.  Prorenin as a reproductive hormone. New form of the renin system. , 1986, The American journal of medicine.

[73]  J. Laragh,et al.  Prorenin in high concentrations in human ovarian follicular fluid. , 1986, Science.

[74]  D. Karnad,et al.  Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. , 1986, British medical journal.

[75]  J. Rouleau,et al.  Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. , 1986, Kidney international.

[76]  J. Laragh,et al.  Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[77]  C. F. Anderson The Kidney: Physiology and Pathophysiology , 1985 .

[78]  F. Trevisani,et al.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites. , 1985, Gut.

[79]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[80]  Z. Katz,et al.  Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. , 1984, International journal of fertility.

[81]  J. Gunnells,et al.  Plasma Norepinephrine in the Evaluation of Baroreceptor Function in Humans , 1982, Hypertension.

[82]  J. Schenker,et al.  Ovarian Hyperstimulation Syndrome: A Current Survey , 1978 .

[83]  T. Starzl,et al.  Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. , 1973, The New England journal of medicine.

[84]  J. Coburn,et al.  Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome , 1969 .